• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE; SURGICAL SEALANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE; SURGICAL SEALANT Back to Search Results
Model Number CLR222US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Not Applicable (3189)
Event Date 02/13/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Attempts to obtain the following information has been performed and the following was received.If the further details are received at a later date a supplemental medwatch will be sent.When was the dehiscence diagnosed? intra-op or post-op? dihiscence post-op in phase 2 recovery please advise of date of initial procedure.Date of procedure (b)(6) 2020 was prineo used during initial procedure? prineo used at time of procedure? what date post op was wound dehiscence noted? (b)(6) 2020.If prineo used during initial procedure, what was the state of the prineo upon noting dehiscence? don¿t know.Were anomalies mentioned about mesh patch observed during initial procedure? don¿t know.Or post op while addressing dehiscence? don¿t know.Photo of dehiscence? no picture.Was there any other treatment provided (product removed; reoperation; prescription steroids; antibiotics prescribed) in addition to more adhesive? if so, please clarify don¿t know.Please indicate any medical or surgical interventions performed.None.Was patient placed under anesthesia to address dehiscence? no.Please describe how was the adhesive was applied.Don¿t know.What prep was used prior to, during or after prineo use? chloroprep.Was a dressing placed over the incision? if so, what type of cover dressing used? opsite 4x4¿s.What is the surgeon¿s opinion of the dehiscence and why it may have occurred? don¿t know.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
 
Event Description
It was reported a patient underwent an circumferential belt lipectomy on (b)(6) 2020 and topical skin adhesive was used.During phase 2 recovery in post op, the patient had some dehiscence.They applied more adhesive.Case completed with another device of the same product code.No device will be returned.Additional information was requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE
Type of Device
SURGICAL SEALANT
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km. 8.3
san lorenzo 00754
*   00754
Manufacturer Contact
kara ditty-bovard
p.o. box 151, route 22 west
somerville, NJ 08876
6107428552
MDR Report Key9884016
MDR Text Key186547237
Report Number2210968-2020-02384
Device Sequence Number1
Product Code OMD
UDI-Device Identifier10705031230996
UDI-Public10705031230996
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133864
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other
Type of Report Initial
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCLR222US
Device Catalogue NumberCLR222US
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/28/2020
Initial Date FDA Received03/26/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-